Paul Rhomberg, BS, MT(ASCP)

Drug Development Manager
JMI Laboratories
North Liberty, Iowa, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1947 - Activity of Rezafungin against Echinocandin–Non-wild type C. glabrata Clinical Isolates from the Rezafungin Surveillance Program (2014–2021)

  Friday, October 13, 2023
  2:15 PM – 2:30 PM US ET

• 1948 - Rise of Candida auris Infections Worldwide and Trends on the Activity of Fosmanogepix and Comparator Agents against C. auris Causing Invasive Infections

  Friday, October 13, 2023
  2:30 PM – 2:45 PM US ET